Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
Appl Radiat Isot ; 201: 111023, 2023 Nov.
Article En | MEDLINE | ID: mdl-37690167

During the physical start-up of the IVG.1M research reactor, which involved the conversion to low-enriched uranium fuel, various studies were conducted using physical mock-ups of the fuel assemblies. The mock-up consisted of 468 model low-enriched uranium fuel elements that were cut into three sections without end coatings at the cut locations. This configuration allowed for the simulation of fuel element decompression and the experimental determination of fission product release into the coolant. The coolant samples obtained from the mock-up were analyzed using a gamma-spectrometer equipped with a high-purity germanium detector. As a result of the studies, the activities of fission products in the coolant and the averaged relative fission product release were determined. The relative release is defined as the ratio of the release rate of reference fission products to its birth rate. For the first time, fission product release was experimentally obtained in a situation simulating the decompression of IVG.1M fuel cladding.

2.
Appl Radiat Isot ; 200: 110942, 2023 Oct.
Article En | MEDLINE | ID: mdl-37459683

For the past ten years, the IVG.1M research reactor has been converted from high-enriched uranium (HEU) fuel to low-enriched uranium (LEU) fuel. Currently, the final stages of the IVG.M reactor conversion, including physical and energy start-ups, are underway. As part of the physical start-up, one of the objectives was to conduct physical studies on the power distribution across the radius and height of the fuel assemblies in water-cooled technological channels. Studies were carried out using the activation gamma-spectrometric method based on correspondence between energy release and measured gamma-radiation activity of fission or activation products. The ENREDI program was used to determine the detailed relative power distribution over radial cross section of fuel assembly. During these experimental studies, relative power distribution along the height and radial cross section of the IVG.1M fuel assembly, as well as power peaking factors were obtained. These studies will make it possible to evaluate the changes in the IVG.1M reactor fuel power profile after the fuel enrichment reduction, and to verify the accuracy of neutronic simulations.

3.
Appl Radiat Isot ; 185: 110259, 2022 Jul.
Article En | MEDLINE | ID: mdl-35504147

In the Republic of Kazakhstan, within the framework of international initiatives on the non-proliferation of nuclear weapons, the IVG.1M research reactor is being converted to low enriched fuel. Due to the change in the fuel composition, it becomes necessary to assess the power density distribution in the fuel assemblies and in the core altogether. Close attention to this parameter is explained by the fact that the non-uniformity of the radial and axial power density fields determines the operating parameters of the reactor, its power, the core resource and the efficiency of fuel utilization. The purpose of this work is approbation of the activation gamma-spectrometry method for determining the power density distribution in the fuel of the IVG.1M research reactor after conversion. Additionally, for a preliminary assessment of the experimental outcomes, the paper presents the MCNP6 calculation results for the power distribution in fuel assemblies and the peaking factors.


Nuclear Reactors , Spectrometry, Gamma
4.
Klin Lab Diagn ; 61(1): 21-4, 2016 Jan.
Article Ru | MEDLINE | ID: mdl-27183725

The sampling of study included 185 examined workers. Out of them 90 work at "Opitnii zavod Neftekhim" (67 females and 23 males) and 95--at "Kaustik" (64 females and 31 males) from various workshops of the given enterprises. To determine biochemical indicators samples of blood, saliva and urine were collected. The study was carried out in concordance with ethic principles of the Helsinki world medical association declaration, 2008 ed. with receiving written consent of patient to participate in study.


Chemical Industry , Hydrocarbons, Aromatic/adverse effects , Occupational Diseases/diagnosis , Occupational Exposure/adverse effects , Adult , Antipyrine/administration & dosage , Antipyrine/blood , Biomarkers/blood , Biomarkers/urine , Catalase/blood , Erythrocytes/chemistry , Erythrocytes/metabolism , Female , Glutathione/blood , Glyceraldehyde-3-Phosphate Dehydrogenases/blood , Hexokinase/blood , Humans , Isoniazid/administration & dosage , Isoniazid/urine , Male , Middle Aged , Occupational Diseases/blood , Occupational Diseases/urine , Peroxidase/blood , Pyruvate Kinase/blood , Saliva/chemistry , Sodium-Potassium-Exchanging ATPase/blood , Sulfhydryl Compounds/blood , Superoxide Dismutase/blood
...